Anterogen
Geumgok
About Anterogen
Anterogen is a bio-venture company specializing in research and development of cell therapy products and orphan drugs using adult stem cells.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Funding stage: IPO
- Last round: Post-IPO Equity (Jan 2022)
- Ticker: kosdaq:065660
- Website: anterogen.com
- Phone: +82-2-2104-0391
Industries & Categories
Biotechnology, Pharmaceutical, Wholesale
Canonical: https://fsome.com/organization/anterogen-1564645 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.